01 Preface Overview

   China's cell industry, under the "quasi-dual track" regulatory system, has formed a relatively complete cell therapy industry chain. The market size is gradually expanding, with the approval and market launch of CAR-T or TCR-T immune cell products, and China's stem cell patents ranking second globally with a figure of 5556, all of which confirm that China's cell industry is developing steadily.

   As the economic center of the southwest region, Chengdu has gathered many bio-pharmaceutical enterprises and talents by relying on an advanced incubation and nurturing system and a cell drug research and development transformation application platform, promoting the vigorous development of Chengdu's bio-pharmaceutical industry. With the advantage of industrial innovation, the 8th CBIC Cell Industry Conference and the 6th China Bio-Pharmaceutical Innovation Cooperation Conference will be held in Chengdu on November 29-30. The conference, themed "New R&D, New Technology, New Development," invites top industry insiders to focus on the latest industry trends, including various sections such as stem cells, immune cells, cell drugs, organoids, exosomes, gene therapy, and more. It allows more cell industry workers to explore cutting-edge information and technology in all aspects, contributing to the high-quality and sustainable development of the cell industry.

02 Conference Time and Place

Event Date: November 29-30

Participation Location: Chengdu, Sichuan

03 Conference Organizing Units

Chengdu High-tech Medical Association

Sichuan Hospital Association

Sichuan Stem Cell Technology and Cell Therapy Association

Sichuan Bioinformatics Society

Sichuan Pharmaceutical Promotion Association

Sichuan Cell Industry Alliance

Sichuan Big Health Industry Association

Chengdu High-tech Medical Convergence Collaborative Innovation Center

Chengdu High-tech Medical Aesthetics Professional Committee

Chengdu High-tech Zone Bio-industry Experts Federation

Chengdu High-tech Medical Hematology and Oncology Professional Committee

Chengdu High-tech Medical Plastic Surgery Professional Committee

Shanghai Bio-Pharmaceutical Industry Association

Shanghai Laboratory Equipment Association

Shanghai Indoor and Environmental Purification Industry Association

Shanghai Bio-Pharmaceutical Science and Technology Development Center

Beijing Life Science and Technology Industry Association

Shenzhen Cell Therapy Technology Association

Shenzhen Bio-Pharmaceutical Promotion Association

Shenzhen Life Science Industry Association

Guangzhou Instrument Industry Association

Zhuhai High-tech Zone Bio-Pharmaceutical and Medical Device Association

Wuhan East Lake National Independent Innovation Demonstration Zone Bio-Pharmaceutical Industry Association

Guangzhou Zhenghe Exhibition Service Co., Ltd.

Shenzhen Zhenghe Exhibition Service Co., Ltd.

04 Conference Agenda

Plenary Session Topics

1. The latest progress in global stem cell research

2. The international process of China's stem cell research

3. National progress and challenges in wound repair

4. Immune checkpoints for cancer and inflammatory diseases

5. Prospects for cell therapy

Cell Industrialization, Diversification, and Innovation Development

1. Embracing the new era of MM treatment with full immunity

2. Safety of in vitro culture of trophoblast stem cells and NK cells

3. Development and quality control of umbilical cord blood and its derivatives

4. Misconceptions about cell quality control and key points of testing technology

5. Introduction to TCR therapy for solid tumors and research on the production process of autologous cell therapy products

6. Application of γδT cells in tumor immune cell therapy

7. Research on new methods for lymphocyte detection based on lateral flow immunoassay technology

8. The latest progress in clinical translational application of NK-T cells

9. Bottlenecks and strategies for CAR-T therapy for solid tumors

3D Cell Culture and Clinical Application of Organoids

1. Construction and application of ciliated organoids - from pathophysiology, toxicology to drug screening

2. 3D bioprinting and construction of bone organoids

3. Exploration of organoids in drug development

4. Disruptive experimental models - organoids and organ-on-a-chip

5. Standardization and industrial upgrading of organoid culture tools

6. Organoid model construction and high-throughput screening application plan

7. Research on the drug resistance mechanism of triple-negative breast cancer based on organoids

8. Research on the drug resistance mechanism of liver and gallbladder tumors based on organoids

Cell Drug Development Forum

1. Development of innovative drugs for digestive diseases and digestive tract tumors

2. Development of universal cell drugs from IPS

3. Research progress of CAR-NK cell drug development

4. Tumor cell line screening platform empowers drug screening and translational research

5. Cell drug development strategy in a new environment

6. CAR-T cell therapy drugs: improving accessibility and promoting standardization

Gene Therapy Drug Development and Application of New Technologies

1. CDMO assists gene therapy

2. Development of AAV gene therapy products for age-related macular degeneration

3. Gene therapy for otology

4. Artificial intelligence assists in the development of gene therapy drugs

5. Development trends of gene editing technology and application in cell drugs

6. Key points of gene editing in GCT applications

7. Development and application of new gene editing tools

Stem Cell Clinical Application and Industrial Transformation

1. Opportunities and challenges of stem cells and gene editing

2. Stem cell therapy for eye diseases

3. Preclinical efficacy evaluation of stem cell drugs

4. Development of iPSC-derived neural precursor cell products

5. Translation from stem cell/exosome laboratory research to clinical application

6. 20 years of stem cell therapy for autoimmune diseases

Exosome Research and Industrialization

1. Focusing on cutting-edge biomaterials to promote transformation and application

2. The role of exosomes from dental sac stem cells in the treatment of periodontitis

3. Targeted exosome anti-tumor drug delivery platform

4. Application of NanoFCM in exosome research and industrialization

5. Large-scale preparation of exosomes and their application in the treatment of immune diseases

6. Exosome research and transformation platform empowers clinical research to accelerate clinical translation

7. Preclinical research on the prevention and treatment of aging-related diseases by stem cell-derived extracellular vesicles

(Note: The agenda is subject to the on-site announcement)

05 Guest Lineup (Partial)